SHL Telemedicine Ltd. Files Form 6-K with SEC

Ticker: SHMLF · Form: 6-K · Filed: Aug 26, 2024 · CIK: 1166834

Shl Telemedicine Ltd 6-K Filing Summary
FieldDetail
CompanyShl Telemedicine Ltd (SHMLF)
Form Type6-K
Filed DateAug 26, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, press-release, registration-statement

TL;DR

SHL Telemedicine filed a 6-K on Aug 26, 2024, referencing a press release and an S-8 registration.

AI Summary

On August 26, 2024, SHL Telemedicine Ltd. announced the issuance of a press release. This Form 6-K filing is incorporated by reference into the Company's Registration Statement on Form S-8 filed on June 9, 2023, under Registration No. 333-272546.

Why It Matters

This filing indicates that SHL Telemedicine Ltd. has released new information to the public, which could contain updates on its business operations or financial status.

Risk Assessment

Risk Level: low — The filing is a routine report of a foreign private issuer and does not contain significant new financial or operational disclosures.

Key Players & Entities

  • SHL Telemedicine Ltd. (company) — Registrant
  • August 26, 2024 (date) — Date of press release and filing
  • June 9, 2023 (date) — Date of S-8 registration statement
  • 333-272546 (registration_number) — S-8 Registration Number

FAQ

What is the primary purpose of this Form 6-K filing?

The primary purpose of this Form 6-K filing is to report the issuance of a press release by SHL Telemedicine Ltd. on August 26, 2024, and to incorporate it by reference into the company's existing Registration Statement on Form S-8.

When was the press release mentioned in the filing issued?

The press release mentioned in the filing was issued on August 26, 2024.

What is the company's principal executive office address?

The company's principal executive offices are located at 90 Yigal Alon Street, Tel Aviv 67891, Israel.

What is the SEC file number for SHL Telemedicine Ltd.?

The SEC file number for SHL Telemedicine Ltd. is 001-41641.

Which registration statement does this 6-K filing incorporate by reference?

This 6-K filing is incorporated by reference into the Company's Registration Statement on Form S-8 filed with the Securities and Exchange Commission on June 9, 2023 (Registration No. 333-272546).

Filing Stats: 200 words · 1 min read · ~1 pages · Grade level 10 · Accepted 2024-08-26 06:00:35

Filing Documents

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File Number: 001-41641 SHL TELEMEDICINE LTD. (Translation of registrant's name into English) 90 Yigal Alon Street Tel Aviv 67891, Israel (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F EXPLANATORY NOTE On August 26, 2024, SHL Telemedicine Ltd. (the " Company ") issued a press release, a copy of which is furnished herewith as Exhibit 99.1. This Form 6-K is incorporated by reference into the Company's Registration Statement on Form S-8 filed with the Securities and Exchange Commission on June 9, 2023 (Registration No. 333-272546). Exhibit Description 99.1 Press release, dated August 26, 2024, issued by the Company. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SHL Telemedicine Ltd. By: /s/ Amir Hai Amir Hai Chief Financial Officer August 26, 2024

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.